Research Comparison
CJC-1295 (without DAC) vs Kisspeptin
A side-by-side research comparison of CJC-1295 (without DAC) and Kisspeptin drawn from Cobalt Peptides' peptide database records.
CJC-1295 (without DAC)
CJC-1295 (without DAC), also known as Modified GRF 1-29 (Mod GRF 1-29), is a short-acting synthetic analog of growth hormone releasing hormone (GHRH). It is designed to stimulate endogenous growth hormone (GH) release in a pulsatile, physiologically consistent manner. Unlike the DAC-modified version, this variant has a very short half-life, allowing precise control over GH pulses and reducing the risk of receptor desensitization. It is primarily used in research focused on recovery, anti-aging, body composition, and endocrine function optimization.
Kisspeptin
Kisspeptin is a family of neuropeptides encoded by the KISS1 gene, acting as an upstream regulator of the reproductive axis through potent stimulation of gonadotropin-releasing hormone (GnRH) neurons. Several active isoforms are derived from a 145-amino acid precursor; kisspeptin-54 is the predominant circulating form and kisspeptin-10 the minimal fragment retaining full receptor binding. It is studied in reproductive endocrinology on that basis. Supplied strictly as a research compound for laboratory use.